ARTL ARTELO BIOSCIENCES INC

Ownership history in MORGAN STANLEY  ·  12 quarters on record

This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in ARTELO BIOSCIENCES INC (ARTL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 1,100 +1,096 +27400.0% 0.00% $5K $13.77
2025 Q2 REDUCED 4 -16 -80.0% 0.00% $53 $39.81
2025 Q1 UNCHANGED 20 0% 0.00% $18 $15.75
2024 Q4 UNCHANGED 20 0% 0.00% $21 $19.08
2024 Q3 UNCHANGED 20 0% 0.00% $22 $20.16
2024 Q2 UNCHANGED 20 0% 0.00% $27 $24.12
2024 Q1 UNCHANGED 20 0% 0.00% $30 $26.64
2023 Q4 UNCHANGED 20 0% 0.00% $28 $25.20
2023 Q3 UNCHANGED 20 0% 0.00% $29 $26.28
2023 Q2 UNCHANGED 20 0% 0.00% $40 $35.82
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ARTL price (monthly, adj. close)
← Back to MORGAN STANLEY Holdings